Protective effects of mutant of acidic fibroblast growth factor against cerebral ischaemia-reperfusion injury in rats

Injury

Volumn 40, Issue 9, 2009, Pages 963-967

  Xu, Hua ^a   Li, Xiao kun ^a   Zheng, Qing ^a   Huang, Ya dong ^a   Yao, Cheng can ^a   Su, Zhi jian ^a   Zhao, Wen ^a   Zhao, Zhuan you ^b  

^a JINAN UNIVERSITY   (China)

^b Tianjing Institute of Medicine   (China)

Author keywords

Anti oxidation; Behaviour deficit; Brain oedema; Cerebral ischaemia reperfusion; Infarct areas; Middle cerebral artery occlusion (MCAO); Mutant of human acidic fibroblast growth factor (MaFGF); Rats

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; MALONALDEHYDE; NIMODIPINE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN HOMOGENATE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; BRAIN EDEMA; BRAIN ISCHEMIA; CEREBRAL INFARCTION; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTOR 1; INFARCTION, MIDDLE CEREBRAL ARTERY; LIGATION; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE CEREBRAL ARTERY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SUPEROXIDE DISMUTASE;

EID: 67651006168     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2009.01.110     Document Type: Article

References (25)

1. Bederson J.B., Pitts L.H., Germano S.M., et al. Evaluation of 2.3.5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17 (1986) 1304-1308
2. Bederson J.B., Pitts L.H., Tsuji M., et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17 (1986) 472-476
3. Belayev L., Alonso O.F., Busto R., et al. Middle cerebral artery occlusion in the rat by intraluminal suture, neurological and pathological evaluation of an improved model. Stroke 27 (1996) 1616-1622
4. Chen C.H., Toung T.J.K., Hurn P.D., et al. Ischemic neuroprotection with selective-opioid receptor agonist is gender specific. Stroke 36 (2005) 1557-1561
5. Cuevas P., Carceller F., Lozano R.M., et al. Protection of rat myocardium by mitogenic and non-mitogenic fibroblast growth factor during post-ischemic reperfusion. Growth Factors 15 (1997) 29-40
6. Cuevas P., Carceller F., Martinez-Coso V., et al. Cardioprotection from ischemia by fibroblast growth factor: role of inducible nitric oxide synthase. Eur J Med Res 4 (1999) 517-524
7. Cuevas P., Carceller F., Martinez-Coso V., et al. Fibroblast growth factor cardioprotection against ischemia-reperfusion injury may involve K+ ATP channels. Eur J Med Res 5 (2000) 145-149
8. Cuevas P., Carceller F., Nieto I., and Gimenez-Gallego G. Spasmolytic effect of acidic fibroblast growth factor in early cerebral vasospasm in the rat. Surg Neurol 49 (1998) 176-179
9. Cuevas P., Carceller F., Ortega S., et al. Hypotensive activity of fibroblast growth factor. Science 254 (1991) 1208-1210
10. Fu X., Cuevas P., and Gimenez-Gallego G. The effects of fibroblast growth factors on ischemic kidney, liver and gut injuries. Chin Med J 111 (1998) 398-403
11. Fu X.B., Li X.K., Wang T., et al. Enhanced anti-apoptosis and gut epithelium protection function of acidic fibroblast growth factor after cancelling of its mitogenic activity. World J Gastroenterol 10 (2004) 3590-3596
12. Gao F., Deng X.M., An T.Z., et al. Acidic fibroblast growth factor correlates with tumor growth. Chin J Vet Sci 22 (2002) 260-261
13. Gu J.Y., Mei J., Huang S.D., et al. Improvement of cardiac function after adenovirus mediated gene transfer of acidic fibroblast growth factor to chronic ischemic myocardium in swine. Med J Chin PLA 27 (2002) 979-980
14. Li Y., Li Q., and Li X.K. Protection of nmaFGF against anoxia/reperfusion injury in isolated rat hearts. Chin J Pathophysiol 21 (2005) 855-858
15. Lin T.N., He Y.Y., Wu G., et al. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24 (1993) 117-121
16. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84-91
17. Lozano R.M., Pineda-Lucena A., Gonzalez C., et al. 1H NMR structural characterization of a nonmitogenic, vasodilatory, ischemia-protector and neuromodulatory acidic fibroblast growth factor. Biochemistry 39 (2000) 4982-4993
18. Mitani A., Oomura Y., Yanase H., and Kataoka K. Acidic fibroblast growth factor delays in vitro ischemia-induced intracellular calcium elevation in gerbil hippocampal slices: a sign of neuroprotection. Neurochem Int 21 (1992) 337-341
19. Nabel E.G., Yang Z.Y., Plautz G., et al. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 362 (1993) 844-846
20. Sasaki K., Oomura Y., Suzuki K., et al. Acidic fibroblast growth factor prevents death of hippocampal CA1 pyramidal cells following ischemia. Neurochem Int 21 (1992) 397-402
21. Weng L.X., Fu X.B., Li X.X., et al. The effects of the modified and the wild type aFGF on the hepatic and renal function afrer guts' ischemia reperfusion. Chin Crit Care Med 16 (2004) 19-21
22. Wu X.P., Su Z.J., Li X.K., et al. High-level expression and purification of a nonmitogenic form of human acidic fibroblast growth factor in Escherichia coli. Protein Express Purif 42 (2005) 7-11
23. Xu H., Hai G.F., Xu H., and Xiang J.Z. Protective effect of non-mitogenic human acidic fibroblast growth factor from renal ischemia-reperfusion injury. Chin J Pathophysiol 24 4 (2008) 552-557
24. Zheng Q., Wang X.F., Wu X.P., and Xu H. The mitogenic activity decline of a haFGF mutant and its mechanism. Chin J Pathophysiol 21 (2005) 446-448
25. Zheng Q., Zhan M., and Xu H. The effect of nmaFGF on SOD and MDA and NO after retinal ischemia-reperfusion injury. Shandong Med 45 (2005) 15-16